Navigation Links
Eurand and GSK Reach Development Milestone

Eurand N.V., a global specialty pharmaceutical company, announced today that Eurand, Inc. and its collaboration partner, GlaxoSmithKline (NYSE: GSK), reached a significant milestone in the development of an orally disintegrating tablet formulation of an undisclosed compound.

GSK has started a registration bioequivalence study for the new formulation and will make a milestone payment of $1 million to Eurand in recognition of the initiation of this biostudy.

"We are delighted with how well this new formulation is progressing for GlaxoSmithKline," said Gearoid Faherty, Chief Executive Officer, Eurand. "Using our Microcaps(R) and AdvaTab(R) technologies, we develop fast dissolving dosage forms that make it easier for patients to take their medicine.

The new formulation for GlaxoSmithKline dissolves in the mouth in approximately 30 seconds without water and without leaving a bitter or sour taste."

GSK intends to file for marketing authorization in the United States by the end of 2007.


'"/>




Page: 1

Related medicine news :

1. Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death
2. Birds Flu Scare Reaches Germany
3. LASIK Treatments Still To Reach Common Man
4. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
5. Number Of Bird Flu Cases In Switzerland Reaches 11
6. Cholera Death Toll Reaches 1,156 in Angola
7. Indonesia’s Bird Flu Death Toll Reaches 3
8. Growth Factors Help Neurons to Reach Their Correct Destination
9. Subsidies For GPs Visits : Agreement Reached
10. Latest Drug for AMD, Beyond The Reach Of Common Man
11. Medical Course in Kerala is Beyond the Reach of NRIs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... January 18, 2017 , ... ... their Vice President of Franchise Development, Paula Turner Pizarro, was recently featured on ... which features the insights of top business leaders from across the globe, provides ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that Mr. Michael Merges, Director of ... Conference, to be held at the Mayflower Hotel, Washington DC, on Jan. 24 ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s resolutions? Need an excuse ... for a reset. The U.S. Apple Association agrees and recommends starting each day ... that contribute to heart disease. , The U.S. Apple Association – which represents apple ...
(Date:1/17/2017)... Chicago, Illinois (PRWEB) , ... January 17, 2017 , ... ... Antonio Breast Cancer Symposium (SABCS) or those who desire a more intimate review and ... Antonio: Breast Cancer – Bench to Bedside—is being offered by Imedex on February 4, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate ... Music Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center ... been the gold standard for high-definition, in-ear earphones. This classic earphone has been ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... manufacturing solutions for cell and advanced therapies , ... the French biopharmaceutical company developing "tumor starvation" treatments ... unmet medical needs. Under the agreement, Invetech will ... products based on Erytech,s proprietary ERYCAPS technology platform, ...
(Date:1/18/2017)... -- After the recent election cycle, it is ... both for medical and recreational purposes are shifting. The evidence ... use of cannabis, but the focus is coming from both ... the North American legal cannabis market posted $6.7 billion in ... research projects sales will grow at a compound annual growth ...
(Date:1/17/2017)... , Jan. 17, 2017 North America Insulin ... new report, "North America Insulin Delivery Market Outlook to ... Insulin Delivery market. The report provides value, in millions ... (USD) within market segments - Insulin Pens, Insulin Pumps, ... report also provides company shares and distribution shares data ...
Breaking Medicine Technology: